Long-Term Cardiovascular Risks of Psychostimulant Drugs for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). Alexander GC, Moore TJ, Brass EP. J Am Coll Cardiol 2024;83:1883-1885.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Alexander GC, Moore TJ, Brass EP. Long-Term Cardiovascular Risks of Psychostimulant Drugs for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). J Am Coll Cardiol 2024;83:1883-1885.
PMID: 38719368